Skip to content

Net Change in Cash at other companies

IAR
Integra LifeSciencesIART
$1.76M+124%
MiMedx Group logo
MiMedx GroupMDXG
-$6.35M-415%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$35.76M+241%
Bioventus logo
BioventusBVS
-$15.39M+18.0%
Artivion logo
ArtivionAORT
-$9.14M+42.0%
Axogen logo
AxogenAXGN
$45.11M+577%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s net change in cash?
Organogenesis Holdings Inc. (ORGO) reported net change in cash of -$2.23M in Q1 2026.
How has Organogenesis Holdings Inc.'s net change in cash changed year-over-year?
Organogenesis Holdings Inc.'s net change in cash increased by 91.3% year-over-year, from -$25.62M to -$2.23M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.